Safacto AF 500 IU

Safacto AF 500 IU contains Moroctocog Alfa, a recombinant human coagulation factor VIII that replaces the missing factor VIII in patients with hemophilia A and helps control bleeding.

Key Information

• Active Ingredient: Moroctocog Alfa
• Strength: 500 IU
• Use: Treatment, prevention and routine prophylaxis of bleeding in patients with hemophilia A.
• Administration: Administered intravenously after reconstitution with the provided solvent.
• Uses: Can be used to manage bleeding episodes and bleeding associated with surgical procedures.
• Important: The dosage depends on the severity of factor VIII deficiency, the location and extent of bleeding, and the patient's clinical condition.

Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Consult a qualified healthcare professional before using this medicine.